BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25329860)

  • 21. Bile duct adenoma: imaging features and radiologic-pathologic correlation.
    Tatsumi R; Ichihara S; Suii H; Yamaguchi M; Arakawa T; Nakajima T; Kuwata Y; Ozeki I; Hige S; Toyota J; Karino Y
    Jpn J Radiol; 2020 Jun; 38(6):561-571. PubMed ID: 32128668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholangiocarcinoma developing in von Meyenburg complexes in haemochromatosis].
    Wisniewski B; Tordjman G; Tran Van Nhieu J; Bettan L; Courillon-Mallet A
    Gastroenterol Clin Biol; 2002 Oct; 26(10):922-4. PubMed ID: 12434102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging features of bile duct adenoma: case series and review of literature.
    Chuy JA; Garg I; Graham RP; VanBuren WM; Venkatesh SK
    Diagn Interv Radiol; 2018 Sep; 24(5):249-254. PubMed ID: 30211677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early changes in cholestatic livers as a consequence of hepatic duct carcinoma: a histological and histochemical exploration.
    James J; Frederiks WM; Van Noorden CJ
    Semin Liver Dis; 1990 May; 10(2):91-101. PubMed ID: 2162570
    [No Abstract]   [Full Text] [Related]  

  • 25. Bile duct adenoma (hamartoma of peribiliary glands): Importance of an adequate diagnosis.
    Fernández Fernández JM; Muriel Cueto P; Sánchez Sánchez AM; Dulanto Vargas M; Bados Nieto P
    Cir Esp; 2015 Oct; 93(8):e95-6. PubMed ID: 24125022
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cholangio-hamartoma of the liver (a new case)].
    Maaouni AB; Maaouni A; Tounsi A; Benyahia TD; Abi F; Rifai N
    Maghrib Tibbi; 1984 Dec; 6(4):345-51. PubMed ID: 6100200
    [No Abstract]   [Full Text] [Related]  

  • 27. CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.
    Gütgemann I; Haas S; Berg JP; Zhou H; Büttner R; Fischer HP
    Virchows Arch; 2006 Apr; 448(4):407-11. PubMed ID: 16411132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahepatic biliary cystadenoma causing luminal common bile duct obstruction.
    Sutton CD; White SA; Berry DP; Dennison AR
    Dig Surg; 2000; 17(3):297-9. PubMed ID: 10867471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile duct adenoma. A study of 152 cases.
    Allaire GS; Rabin L; Ishak KG; Sesterhenn IA
    Am J Surg Pathol; 1988 Sep; 12(9):708-15. PubMed ID: 3046396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile duct carcinoma in chronic ulcerative colitis.
    Roberts-Thomson IC; Strickland RG; Mackay IR
    Aust N Z J Med; 1973 Jun; 3(3):264-7. PubMed ID: 4354244
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholangiocarcinoma with bile duct adenoma and hamartoma-like lesion in the bile duct].
    Takahashi S; Takada K; Kawano Y; Miyanishi K; Ishiwatari H; Hayashi T; Sagawa T; Sato T; Sato Y; Takimoto R; Kobune M; Kuroiwa G; Hirayama M; Tobioka H; Hirata K; Omatsu M; Hasegawa T; Kato J
    Nihon Shokakibyo Gakkai Zasshi; 2010 Mar; 107(3):461-9. PubMed ID: 20203450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor.
    Oda E; Yamamura K; Hara Y; Matsumura K; Akahoshi S; Yuki H; Motohara T; Miyamoto H; Kinoshita K; Matsumura F; Ohnishi K; Komohara Y; Beppu T
    Anticancer Res; 2021 Oct; 41(10):5249-5254. PubMed ID: 34593478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatitis complicating mucin-hypersecreting common bile duct adenoma.
    Katsinelos P; Basdanis G; Chatzimavroudis G; Karagiannoulou G; Katsinelos T; Paroutoglou G; Papaziogas B; Paraskevas G
    World J Gastroenterol; 2006 Aug; 12(30):4927-9. PubMed ID: 16937485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metastatic bile duct cancer in secondary biliary cirrhosis associated with primary sclerosing cholangitis in ulcerative colitis].
    Böckmann S; Bernhardt-Huth D; Huth F; Fritsch WP
    Z Gastroenterol; 1990 Jul; 28(7):363-7. PubMed ID: 2173291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic bile duct carcinoma and C. sinensis infection in Hong Kong.
    Belamaric J
    Cancer; 1973 Feb; 31(2):468-73. PubMed ID: 4347190
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    J Pathol; 1998 Jun; 185(2):191-8. PubMed ID: 9713347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
    Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
    Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
    Sirica AE; Radaeva S; Caran N
    Am J Pathol; 1997 Dec; 151(6):1685-94. PubMed ID: 9403719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.